SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine plus immunotherapy shows promise against tough lung cancer
Disease control Recruiting nowThis study tests whether adding a personalized cancer vaccine (V940) to standard immunotherapy (pembrolizumab) and chemotherapy helps people with advanced squamous non-small cell lung cancer live longer and keep their cancer from growing. About 180 participants will receive eithe…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New pill shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new oral drug, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if it can shrink tumors or slow cancer growth. About 200 adults with specific cancers like ovarian, lung, or breas…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New drug ALE.P02 targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called ALE.P02 in people with advanced squamous cell cancers of the lung, head and neck, cervix, or esophagus. The drug is designed to target a protein called Claudin-1 found on these cancer cells. The main goals are to check the drug's safety, find th…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug AZD8205 tested in advanced cancers: hope for Hard-to-Treat tumors?
Disease control Recruiting nowThis study tests a new drug called AZD8205, alone or with other cancer drugs, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have spread or come back. The main goals are to check safety and find the right dose. About 460 adults whose cancer has n…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New Antibody-Drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called ALE.P03 in adults with advanced cancers (cervical, lung, colorectal, bile duct, or bladder) that have not responded to standard treatments. The drug is an antibody-drug conjugate designed to target a protein called Claudin-1 found on these tumor…
Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated May 04, 2026 16:22 UTC